SUGANDHA TIJORIWALA: Open Payments
NPI 1730831918 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $211 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| ABBVIE INC. | 2 | $37 |
| UCB, Inc. | 2 | $36 |
| Braeburn Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Indivior Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, Nayzilam, BRIXADI, Auvelity, XIFAXAN, SUBLOCADE.
Industry payments across MI — which companies pay providers there.
